Mod-GRF (1-29)

Mod-GRF (1-29) is an engineered peptide derived from growth hormone-releasing hormone, discussed in relation to stimulation of growth hormone secretion. The supplied guide attributes several potential physiological benefits to it, but the notes do not establish clinical efficacy.

Endogenous growth hormone-releasing hormone helps regulate growth hormone output from the pituitary gland. Growth hormone secretion normally occurs in discrete bursts, making the duration of a stimulating signal relevant to its physiological effects. The guide distinguishes this peptide from DAC-containing CJC-1295 on the basis of a shorter duration of activity.

The proposed mechanism involves stimulation of pituitary growth hormone release through GHRH-related signaling. The guide suggests that brief activity may strengthen secretory bursts rather than sustain continuous hormone elevation. Whether this reliably reproduces normal secretion patterns is not established by the supplied material.

1. 01

   Molecular target

2. 02

   Cellular signal

3. 03

   Biological process

LEVEL 01 · Basic biology

A biological mechanism or molecular interaction is described. No claim about human outcomes.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

The source guide presents Mod-GRF (1-29) as a relatively short-acting stimulus for growth hormone secretion. It associates the compound with potential changes in muscle and adipose tissue, repair processes, skin characteristics, and energy regulation. The guide also portrays tolerability favorably and suggests fewer adaptive endocrine effects than longer-acting comparators, without providing supporting evidence in the extracted notes.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

The supplied material does not identify studies sufficient to assess clinical benefits, pharmacokinetics, or comparative endocrine risks. Claims about physiological pulse preservation and reduced desensitization require independent verification.

Safety data are limited, and the guide's favorable characterization should not be interpreted as evidence of established safety. It mentions flushing, localized redness or swelling, fluid accumulation, and altered sensation, but their frequency, severity, and relationship to exposure are unclear. This information is not medical advice.

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

• “Mod-GRF 1-29 growth hormone secretion”
• “Mod-GRF peptide for muscle repair”
• “Mod-GRF 1-29 clinical use”

Editorial status

source reviewed

Last updated

2026-09-14

Last reviewed

2026-09-13

Language

EN